Drugs / porfimer sodium
last change Oct 2025 re-read 9 days ago

porfimer sodium

Small molecule

Developed for
non-small cell lung carcinoma · head and neck cancer · lung cancer · malignant mesothelioma · extrahepatic bile duct carcinoma · gallbladder cancer · pleural disorder · bile duct cancer
+25 more · brain cancer · central nervous system cancer · esophageal adenocarcinoma · esophageal cancer · esophageal squamous cell carcinoma · gallbladder carcinoma · head and neck carcinoma · hepatocellular carcinoma · hilar cholangiocarcinoma · larynx verrucous carcinoma · malignant glioma · malignant pancreatic neoplasm · metastatic malignant neoplasm · metastatic squamous cell carcinoma · obstructive jaundice · oropharynx squamous cell carcinoma · pancreatic acinar cell carcinoma · pancreatic ductal adenocarcinoma · pleural epithelioid mesothelioma · precancerous condition · small cell lung carcinoma · superficial urinary bladder carcinoma · tongue carcinoma · verrucous carcinoma of oral cavity · central nervous system neoplasm
Investigated by
Roswell Park Cancer Institute · National Cancer Institute (NCI) · Pinnacle Biologics Inc. · Concordia Laboratories Inc. · Abramson Cancer Center at Penn Medicine · Harry T Whelan, MD
+16 more · American Society for Gastrointestinal Endoscopy · Axcan Pharma · Colorado Health Foundation · John DeWitt · Jonsson Comprehensive Cancer Center · Lumeda,Inc. · Memorial Sloan Kettering Cancer Center · North Florida Foundation for Research and Education · North Florida/South Georgia Veterans Health System · Ohio State University Comprehensive Cancer Center · Samsung Medical Center · Simphotek Inc. · Taoyuan General Hospital · The First Affiliated Hospital of Henan University of Science and Technology · University College, London · University of Miami

Regulatory milestones approvals, filings & regulatory actions · 6 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Withdrawn EU (EMA) PhotoBarr — 2012-04-20 europa.eu ↗
Label expansions (3) US (FDA) PHOTOFRIN — 1998-01-09 – 2008-09-08 fda.gov ↗
Approved EU (EMA) PhotoBarr — 2004-03-25 europa.eu ↗
Approved US (FDA) PHOTOFRIN — 1995-12-27 fda.gov ↗

Trials 28

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 01 trial
Phase 0 NCT04753918 Mar → Sep 2021 non-small cell lung carcinoma Taoyuan General Hospital Unknown No outcome recorded
Phase 18 trials
Phase 1 NCT04836429 Mar 2022 → Feb 2024 non-small cell lung carcinoma, pleural disorder Roswell Park Cancer Institute Terminated No outcome recorded Stop: Enrollment
Phase 1 NCT03678350 Sep 2021 → Nov 2023 malignant mesothelioma, non-small cell lung carcinoma, pleural disorder Roswell Park Cancer Institute Completed No outcome recorded
Phase 1 NCT03727061 Jul 2019 → Oct 2024 head and neck carcinoma Roswell Park Cancer Institute Terminated No outcome recorded Stop: Enrollment
Phase 1 NCT03344861 Aug 2017 → Mar 2019 lung cancer Concordia Laboratories Inc. Completed No outcome recorded
Phase 1 NCT02916745 Jan 2017 → Apr 2019 non-small cell lung carcinoma Concordia Laboratories Inc. Completed No outcome recorded
Phase 1 NCT01770132 Apr 2013 → Jul 2017 pancreatic acinar cell carcinoma, pancreatic ductal adenocarcinoma John DeWitt Completed No outcome recorded
Phase 1 NCT01682746 Mar 2013 → Jun 2018 brain cancer Harry T Whelan, MD Completed No outcome recorded
Phase 1 NCT00014066 Mar 1993 → Feb 2004 lung cancer Roswell Park Cancer Institute Completed No outcome recorded
Phase 1/22 trials
Phase 1/2 NCT03735095 Feb 2020 → Jul 2024 non-small cell lung carcinoma, small cell lung carcinoma Roswell Park Cancer Institute Completed No outcome recorded
Phase 1/2 NCT00322699 Feb 2005 → Apr 2010 superficial urinary bladder carcinoma North Florida/South Georgia Veterans Health System Completed No outcome recorded
Phase 29 trials
Phase 2 NCT01966809 Jun 2015 → Dec 2017 malignant glioma Harry T Whelan, MD Terminated No outcome recorded Stop: Enrollment
Phase 2 NCT02153229 Jun 2014 → Dec 2026 expected pleural epithelioid mesothelioma Abramson Cancer Center at Penn Medicine Active not recruiting No outcome recorded
Phase 2 NCT02068157 Apr 2014 → Oct 2016 larynx verrucous carcinoma, metastatic squamous cell carcinoma, oropharynx squamous cell carcinoma, tongue carcinoma +1 Roswell Park Cancer Institute Terminated No outcome recorded
Phase 2 NCT00601848 Nov 2004 → Feb 2012 lung cancer, metastatic malignant neoplasm Abramson Cancer Center at Penn Medicine Terminated No outcome recorded Stop: Enrollment
Phase 2 NCT00453336 Jun 2003 → Aug 2009 head and neck cancer, precancerous condition University of Miami Completed No outcome recorded
Phase 2 NCT00054002 Mar 1999 → Jun 2006 malignant mesothelioma Roswell Park Cancer Institute Completed No outcome recorded
Phase 2 NCT00003923 Mar 1999 → Feb 2002 extrahepatic bile duct carcinoma, gallbladder cancer, malignant pancreatic neoplasm Memorial Sloan Kettering Cancer Center Completed No outcome recorded
Phase 2 NCT00002935 Oct 1995 → Aug 2006 esophageal cancer Roswell Park Cancer Institute Completed No outcome recorded
Phase 2 NCT00002964 Feb 1995 → Apr 2004 head and neck cancer Roswell Park Cancer Institute Completed No outcome recorded
Phase 35 trials
Phase 3 NCT02628665 Oct 2015 → Oct 2017 esophageal adenocarcinoma, esophageal squamous cell carcinoma The First Affiliated Hospital of Henan University of Science and Technology Unknown No outcome recorded
Phase 3 NCT02082522 Nov 2014 → Jan 2017 hilar cholangiocarcinoma Concordia Laboratories Inc. Terminated No outcome recorded Stop: Enrollment
Phase 3 NCT00513539 Jul 2007 → Dec 2009 bile duct cancer, gallbladder cancer University College, London Completed No outcome recorded
Phase 3 NCT00003788 Apr 1998 → ? central nervous system cancer Colorado Health Foundation Unknown No outcome recorded
Phase 3 NCT00253617 — extrahepatic bile duct carcinoma, gallbladder carcinoma Jonsson Comprehensive Cancer Center Withdrawn No outcome recorded
Phase not applicable3 trials
— NCT02106559 Sep 2014 → Jan 2016 malignant mesothelioma, non-small cell lung carcinoma Ohio State University Comprehensive Cancer Center Withdrawn No outcome recorded
— NCT01506115 Sep 2009 → Mar 2011 hepatocellular carcinoma, obstructive jaundice Samsung Medical Center Completed No outcome recorded
— NCT00530088 Oct 2001 → Aug 2010 head and neck cancer Roswell Park Cancer Institute Terminated No outcome recorded
Comparator or background therapy1 trial
Phase 3 NCT00118222 Comparator Mar 2005 → Mar 2006 central nervous system neoplasm Case Comprehensive Cancer Center Completed No outcome recorded

Evidence & citations 11 cited values

Every value below carries the sentence it was read from. 30 sources stand behind the page.

FieldValueCited text
Known as porfimer sodium “Photodynamic therapy (PDT) is a combination of a drug, porfimer sodium (Photofrin), which is activated by a light from a laser that emits no heat.” NCT02082522 ↗
23

“Everyone in this study will receive Photofrin® (porfimer sodium) for injection (Pinnacle Biologics, Inc., Bannockburn, IL, USA)” NCT01966809 ↗

“Photofrin (porfimer sodium) photodynamic therapy.” NCT01682746 ↗

NCT03678350 ↗

NCT03735095 ↗

NCT03344861 ↗

NCT00513539 ↗

NCT03727061 ↗

NCT00003923 ↗

NCT00453336 ↗

NCT00601848 ↗

Show 13 more sources

Known as CL 184,116 ChEMBL registry synonym — accepted as the source's own label CHEMBL1201481 ↗
Known as Photobarr ChEMBL registry synonym — accepted as the source's own label CHEMBL1201481 ↗
Known as Photofrin “To determine the feasibility and toxicities of incorporating surgical resection and intra-operative Photofrin (porfimer sodium)-mediated photodynamic therapy in patients (pts)...” NCT02106559 ↗
11

“OBJECTIVES: I. Evaluate the efficacy of photodynamic therapy (PDT) using porfimer sodium (Photofrin) and controlled uniform laser light in patients with carcinoma in situ in...” NCT00002935 ↗

“Photodynamic therapy (PDT) is a combination of a drug, porfimer sodium (Photofrin), which is activated by a light from a laser that emits no heat.” NCT02082522 ↗

“Photofrin solution is administered slowly as a bolus injection over 3-5 minutes on day 1.” NCT00014066 ↗

“Patients receive porfimer sodium (Photofrin) IV one day prior to surgery.” NCT00003788 ↗

“Patients receive porfimer sodium (Photofrin®) IV over 5-15 minutes.” NCT00601848 ↗

NCT02628665 ↗

NCT00322699 ↗

NCT02153229 ↗

NCT01682746 ↗

NCT01506115 ↗

Show 1 more source

Known as Photofrin ii ChEMBL registry synonym — accepted as the source's own label CHEMBL1201481 ↗
Known as Porfimere sodique ChEMBL registry synonym — accepted as the source's own label CHEMBL1201481 ↗
Known as Porfimero de sodio ChEMBL registry synonym — accepted as the source's own label CHEMBL1201481 ↗
Known as Profimer sodium ChEMBL registry synonym — accepted as the source's own label CHEMBL1201481 ↗
Modality Other / unclassified “the photosensitizer prior to surgery” NCT02153229 ↗
Modality Small molecule — CHEMBL1201481 ↗
Route Intravenous “PDT consists of IV porfimer sodium” NCT00002935 ↗